These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9023291)

  • 21. Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
    Brocco M; Dekeyne A; Mannoury la Cour C; Touzard M; Girardon S; Veiga S; de Nanteuil G; deJong TR; Olivier B; Millan MJ
    Eur Neuropsychopharmacol; 2008 Oct; 18(10):729-50. PubMed ID: 18657401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M; Boczek-Leszczyk E
    J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.
    Sakurada S; Orito T; Furuta S; Watanabe H; Mobarakeh JI; Yanai K; Watanabe T; Sato T; Onodera K; Sakurada C; Sakurada T
    Pharmacol Biochem Behav; 2003 Jan; 74(2):487-93. PubMed ID: 12479971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
    Zeng XP; Burcher E
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat.
    Couture R; Toma N; Barbot L
    Life Sci; 2000; 66(1):51-65. PubMed ID: 10658924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
    Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
    Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.
    Steinberg R; Alonso R; Rouquier L; Desvignes C; Michaud JC; Cudennec A; Jung M; Simiand J; Griebel G; Emonds-Alt X; Le Fur G; Soubrié P
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1180-8. PubMed ID: 12438542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
    McLean S; Ganong A; Seymour PA; Snider RM; Desai MC; Rosen T; Bryce DK; Longo KP; Reynolds LS; Robinson G
    J Pharmacol Exp Ther; 1993 Oct; 267(1):472-9. PubMed ID: 7693914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-nociceptive effects of selectively destroying substance P receptor-expressing dorsal horn neurons using [Sar9,Met(O2)11]-substance P-saporin: behavioral and anatomical analyses.
    Wiley RG; Kline RH; Vierck CJ
    Neuroscience; 2007 May; 146(3):1333-45. PubMed ID: 17418497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neurokinin-1 receptor antagonist LY306,740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression.
    McCarson KE; Krause JE
    Mol Pharmacol; 1996 Nov; 50(5):1189-99. PubMed ID: 8913350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ava[L-Pro9,N-MeLeu10] substance P(7-11) (GR 73632) and Sar9, Met(O2)11 increase distention-induced peristalsis through activation of neurokinin-1 receptors on smooth muscle and interstitial cells of cajal.
    Nieuwmeyer F; Ye J; Huizinga JD
    J Pharmacol Exp Ther; 2006 Apr; 317(1):439-45. PubMed ID: 16330493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Amos B; Alkam T
    Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
    Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal actions of GR73632, a novel tachykinin NK1 receptor agonist.
    Sakurada C; Watanabe C; Inoue M; Tan-No K; Ando R; Kisara K; Sakurada T
    Peptides; 1999; 20(2):301-4. PubMed ID: 10422886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis.
    Hood VC; Cruwys SC; Urban L; Kidd BL
    Regul Pept; 2000 Dec; 96(1-2):17-21. PubMed ID: 11102647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats.
    Vassout A; Veenstra S; Hauser K; Ofner S; Brugger F; Schilling W; Gentsch C
    Regul Pept; 2000 Dec; 96(1-2):7-16. PubMed ID: 11102646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological properties of FK886, a new, centrally active neurokinin-1 receptor antagonist.
    Yoshino-Furukawa T; Maeda Y; Kikuchi A; Sakuma H; Imazumi K; Yamakuni H; Sogabe H; Matsuo M; Manda T; Uchida W
    Biol Pharm Bull; 2013; 36(1):76-81. PubMed ID: 23302639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
    Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
    Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A selective and extremely potent antagonist of the neurokinin-1 receptor.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
    Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions.
    Altier N; Stewart J
    Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.